RAS BiologyБиохимия Biochemistry

  • ISSN (Print) 0320-9725
  • ISSN (Online) 3034-5294

ALPHA- AND GAMMA-SYNUCLEINS CONTROL ENERGY METABOLISM AND ACTIVITY OF XANTHIN OXIDASE IN BRAIN CELLS

PII
S30345294S0320972525100061-1
DOI
10.7868/S3034529425100061
Publication type
Article
Status
Published
Authors
Volume/ Edition
Volume 90 / Issue number 10
Pages
1487-1496
Abstract
The process of transmission and transformation of signal in the central nervous system causes large energy expenditures in brain cells, which leads to active energy metabolism with high consumption of glucose and oxygen. Production of reactive oxygen species (ROS) as a result of these processes participate in signal transduction in the cell, but overproduction of ROS leads to the development of oxidative stress. Oxidative stress and aggregation of the α-synuclein is a hallmark in the mechanism of neuronal loss in Parkinson's disease. However, much less is known about the physiological role of monomeric synucleins. Using acute brain slices and primary neuroglial co-cultures prepared from transgenic mice with knockout of α-, β-, and γ-synuclein genes, we studied the role of these proteins in ROS production and energy metabolism. We found that synuclein knockout results in reduced ROS production compared to wild-type cells. Xanthine oxidase (XO) inhibitor oxypurinol reduced ROS production in wild-type cells and β-synuclein knockout brain slices, while XO-dependent ROS was not inhibited in α- or γ-synuclein knockout slices, suggesting that these proteins may regulate this enzyme. Knockout of α- and γ-synucleins resulted in a decrease in mitochondrial membrane potential and a reduction in energy capacity (in the form of ATP), which may be one of the mechanisms of XO regulation by synucleins.
Keywords
синуклеины активные формы кислорода ксантиноксидаза нейрон астроцит
Date of publication
01.10.2025
Year of publication
2025
Number of purchasers
0
Views
10

References

  1. 1. Angelova, P. R., Esteras, N., and Abramov, A. Y. (2021) Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: finding ways for prevention, , 41, 770-784, https://doi.org/10.1002/med.21712.
  2. 2. Gleichmann, M., and Mattson, M. P. (2011) Neuronal calcium homeostasis and dysregulation, , 14, 1261-1273, https://doi.org/10.1089/ars.2010.3386.
  3. 3. Angelova, P. R., and Abramov, A. Y. (2018) Role of mitochondrial ROS in the brain: from physiology to neurodegeneration, , 592, 692-702, https://doi.org/10.1002/1873-3468.12964.
  4. 4. Gandhi, S., and Abramov, A. Y. (2012) Mechanism of oxidative stress in neurodegeneration, , 2012, 428010, https://doi.org/10.1155/2012/428010.
  5. 5. Burrage, E. N., Colbentz, T., Prabhu, S. S., Childers, R., Bryner, R. W., Lewis, S. E., DeVallance, E., Kelley, E. E., and Chandler, P. D. (2023) Xanthine oxidase mediates chronic stress-induced cerebrovascular dysfunction and cognitive impairment, , 43, 905-920, https://doi.org/10.1177/0271678X231152551.
  6. 6. Angelova, P. R., Myers, I., and Abramov, A. Y. (2023) Carbon monoxide neurotoxicity is triggered by oxidative stress induced by ROS production from three distinct cellular sources, , 60, 102598, https://doi.org/10.1016/j.redox.2022.102598.
  7. 7. Abramov, A. Y., Scorziello, A., and Duchen, M. R. (2007) Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation, , 27, 1129-1138, https://doi.org/10.1523/JNEUROSCI.4468-06.2007.
  8. 8. Xia, Y., and Zweier, J. L. (1995) Substrate control of free radical generation from xanthine oxidase in the postischemic heart, , 270, 18797-18803, https://doi.org/10.1074/jbc.270.32.18797.
  9. 9. Kinugasa, Y., Ogino, K., Furuse, Y., Shiomi, T., Tsutsui, H., Yamamoto, T., Igawa, O., Hisatome, I., and Shigemasa, C. (2003) Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts, , 67, 781-787, https://doi.org/10.1253/circj.67.781.
  10. 10. Thies, J. L., Willicott, K., Craig, M. L., Greene, M. R., DuGay, C. N., Caldwell, G. A., and Caldwell, K. A. (2023) Xanthine dehydrogenase is a modulator of dopaminergic neurodegeneration in response to bacterial metabolite exposure in , , 12, 1170, https://doi.org/10.3390/cells12081170.
  11. 11. Abramov, A.Y., Potapova, E. V., Dremin, V. V., and Dunaev, A. V. (2020) Interaction of oxidative stress and misfolded proteins in the mechanism of neurodegeneration, , 10, 1-14, https://doi.org/10.3390/life10070101.
  12. 12. Calabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., and Ghiglieri, V. (2023) Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction, , 14, 176, https://doi.org/10.1038/s41419-023-05672-9.
  13. 13. Negi, S., Khurana, N., and Duggal, N. (2024) The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease, , 177, 105760, https://doi.org/10.1016/j.neuint.2024.105760.
  14. 14. Magistrelli, L., Contaldi, E., and Comi, C. (2021) The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson's disease, , 11, 804, https://doi.org/10.3390/life11080804.
  15. 15. Guo, Y., Sun, Y., Song, Z., Zheng, W., Xiong, W., Yang, Y., Yuan, L., and Deng, H. (2021) Genetic analysis and literature review of SNCA variants in Parkinson's disease, , 13, 648151, https://doi.org/10.3389/fnagi.2021.648151.
  16. 16. Clayton, D. F., and George, J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, , 21, 249-254, https://doi.org/10.1016/S0166-2236 (97)01213-7.
  17. 17. Guschina, I. A., Ninkina, N., Roman, A., Pokrovskiy, M. V., and Buchman, V. L. (2021) Triple-knockout, synuclein-free mice display compromised lipid pattern, , 26, 1-22, https://doi.org/10.3390/molecules26113078.
  18. 18. George, J. M. (2002) The synucleins, , 3, REVIEWS3002, https://doi.org/10.1186/gb-2001-3-1-reviews3002.
  19. 19. Ninkina, N., Connor-Robson, N., Ustyugov, A. A., Tarasova, T. V., Shelkovnikova, T. A., and Buchman, V. L. (2015) A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous gene expression, , 5, 1-6, https://doi.org/10.1038/srep16615.
  20. 20. Kokhan, V. S., Van'kin, G. I., Bachurin, S. O., and Shamakina, I. Y. (2013) Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice, , 14, 53, https://doi.org/10.1186/1471-2202-14-53.
  21. 21. Ninkina, N., Tarasova, T. V., Chaprov, K. D., Roman, A. Y., Kukharsky, M. S., Kolik, L. G., Ovchinnikov, R., Ustyugov, A. A., Durnev, A. D., and Buchman, V. L. (2020) Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice, , 91, 76-87, https://doi.org/10.1016/j.neurobiolaging.2020.02.026.
  22. 22. Greten-Harrison, B., Polydoro, M., Morimoto-Tomita, M., Diao, L., Williams, A. M., Nie, E. H., Makani, S., Tian, N., Castillo, P. E., Buchman, V. L., and Chandra, S. S. (2010) αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction, , 107, 19573-19578, https://doi.org/10.1073/pnas.1005005107.
  23. 23. Vorobyov, V., Deev, A., Sukhanova, I., Morozova, O., Oganesyan, Z., Chaprov, K., and Buchman, V. L. (2022) Loss of the synuclein family members differentially affects baseline- and apomorphine-associated EEG determinants in single-, double- and triple-knockout mice, , 10, 3128, https://doi.org/10.3390/biomedicines10123128.
  24. 24. Furuhashi, M. (2020) New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity, , 319, E827-E834, https://doi.org/10.1152/ajpendo.00378.2020.
  25. 25. Starr, L. A., McKay, L. E., Peter, K. N., Seyfarth, L. M., Berkowitz, L. A., Caldwell, K. A., and Caldwell, G. A. (2023) Attenuation of dopaminergic neurodegeneration in a Parkinson's model through regulation of xanthine dehydrogenase (XDH-1) expression by the RNA editase, ADR-2, , 11, 20, https://doi.org/10.3390/jdb11020020.
  26. 26. Ludtmann, M. H. R., Angelova, P. R., Ninkina, N. N., Gandhi, S., Buchman, V. L., and Abramov, A. Y. (2016) Monomeric alpha-synuclein exerts a physiological role on brain ATP synthase, , 36, 10510-10521, https://doi.org/10.1523/JNEUROSCI.1659-16.2016.
  27. 27. Ludtmann, M. H. R., Angelova, P. R., Horrocks, M. H., Choi, M. L., Rodrigues, M., Baev, A. Y., Berezhnov, A. V., Yao, Z., Little, D., Banushi, B., Al-Menhali, A. S., Ranasinghe, R. T., Whiten, D. R., Yapom, R., Dolt, K. S., Devine, M. J., Gissen, P., Kunath, T., Jaganjac, M., Pavlov, E. V., Klenerman, D., Abramov, A. Y., and Gandhi, S. (2018) α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease, , 9, 2293, https://doi.org/10.1038/s41467-018-04422-2.
  28. 28. Abramov, A. Y., Berezhnov, A. V., Fedotova, E. I., Zinchenko, V. P., and Dolgacheva, L. P. (2017) Interaction of misfolded proteins and mitochondria in neurodegenerative disorders, , 45, 1025-1033, https://doi.org/10.1042/BST20170024.
  29. 29. Deas, E., Cremades, N., Angelova, P. R., Ludtmann, M. H. R., Yao, Z., Chen, S., Horrocks, M. H., Banushi, B., Little, D., Devine, M. J., Gissen, P., Klenerman, D., Dobson, C.M., Wood, N. W., Gandhi, S., and Abramov, A. Y. (2016) Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease, , 24, 376-391, https://doi.org/10.1089/ars.2015.6343.
  30. 30. Angelova, P. R., Choi, M.L., Berezhnov, A. V., Horrocks, M. H., Hughes, C. D., De, S., Rodrigues, M., Yapom, R., Little, D., Dolt, K. S., Kunath, T., Devine, M.J., Gissen, P., Shchepinov, M. S., Sylantyev, S., Pavlov, E. V., Klenerman, D., Abramov, A. Y., and Gandhi, S. (2020) Alpha synuclein aggregation drives ferropiosis: an interplay of iron, calcium and lipid peroxidation, , 27, 2781-2796, https://doi.org/10.1038/s41418-020-0542-z.
  31. 31. Moorhouse, P. C., Grootveld, M., Halliwell, B., Quinlan, J. G., and Gutteridge, J. M. C. (1987) Allopurinol and oxypurinol are hydroxyl radical scavengers, , 213, 23-28, https://doi.org/10.1016/0014-5793 (87)81458-8.
  32. 32. Grootveld, M., Halliwell, B., and Moorhouse, C. P. (1987) Action of uric acid, allopurinol and oxypurinol on the myeloperoxidase-derived oxidant hypochlorous acid, , 4, 69-76, https://doi.org/10.3109/10715768709088090.
  33. 33. Harrison, R. (2004) Physiological roles of xanthine oxidoreductase, , 363-375, https://doi.org/10.1081/DMR-120037569.
  34. 34. Guschina, I., Millership, S., O'Donnell, V., Ninkina, N., Harwood, J., and Buchman, V. (2011) Lipid classes and fatty acid patterns are altered in the brain of γ-synuclein null mutant mice, , 46, 121-130, https://doi.org/10.1007/s11745-010-3486-0.
  35. 35. Millership, S., Ninkina, N., Rochford, J. J., and Buchman, V. L. (2013) γ-synuclein is a novel player in the control of body lipid metabolism, , 2, 276-278, https://doi.org/10.4161/adip.25162.
  36. 36. Zhang, H., Kouadio, A., Cartledge, D., and Godwin, A. K. (2011) Role of gamma-synuclein in microtubule regulation, , 317, 1330-1339, https://doi.org/10.1016/j.yexcr.2010.10.013.
  37. 37. Angelova, P. R., Esteras, N., Evans, J., Kostic, M., Melki, R., Prehn, J. H. M., Gandhi, S., Abramov, A. Y. (2025) α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons, , 86, 103817, https://doi.org/10.1016/j.redox.2025.103817.
QR
Translate

Indexing

Scopus

Scopus

Scopus

Crossref

Scopus

Higher Attestation Commission

At the Ministry of Education and Science of the Russian Federation

Scopus

Scientific Electronic Library